Delivery Order SPE2DR25D3501-SPE2DR26FL8UM
Award Date 11/17/25
Potential Completion Date 11/18/25
Potential Value $4.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,648.95 to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Actemra 400 mg/20 mL vials. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 28, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $21,612.59 delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 mL vials. This competitively awarded, firm fixed-price contract was executed on October 28, 2025, with an ultimate completion date of October 29, 2025, and will be performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. The award represents a single delivery order issued under a larger contract vehicle rather than a standalone...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Actemra 400 mg/20 ml vials, with a contract ceiling value of $3,788.05 and an ultimate completion date of November 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this...
- The Defense Logistics Agency awarded a $3,729.39 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Actemra 200 mg/10 mL vials. The contract, which is a firm fixed price delivery order with an ultimate completion date of August 20, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). This award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Actemra 400 mg/20 mL vials with a ceiling value of $16,140.74. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and maintains an ultimate completion date of October 15, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $20,481.14 delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Actemra 400 mg/20 ml vials. This is a firm fixed price, non-set-aside contract with a completion date of May 9, 2025, and performance will be conducted at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Actemra 400 mg/20 ml vials with a ceiling value of $3,543.28 and a firm fixed price structure. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The award was made on a competitive basis...
- The Defense Logistics Agency (DLA) awarded a $13,171.30 delivery order to AmerisourceBergen Drug Corp for 4,568,832,740 units of Actemra 400 mg/20 mL vials on July 18, 2025, with an ultimate completion date of July 21, 2025. This is a firm fixed-price, non-set-aside contract with place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Actemra 400 mg/20 mL vials. This competitively awarded, firm fixed-price delivery order has a ceiling value of $7,109.81 and an ultimate completion date of July 30, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Actemra (tocilizumab) is a biologic immunosuppressant...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Actemra 162 mg/0.9 mL syringes valued at $19,277.63. This is a firm fixed-price delivery order with an ultimate completion date of November 14, 2025, and represents performance at the vendor's location in Conshohocken, Pennsylvania. The award was made through competitive procurement with no set-aside designation, demonstrating AmerisourceBergen's capability to compete...